Prader-Willi syndrome: The care and treatment of infants, children, and adults

Advances in Pediatrics

Volumn 51, Issue , 2004, Pages 409-434

  Zipf, William B ^a  

^a Prader Willi Syndrome Care Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; GHRELIN; GROWTH HORMONE DERIVATIVE; INSULIN; METFORMIN; STEROID HORMONE;

BEHAVIOR; BODY WEIGHT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIET; ENDOCRINE DISEASE; EXERCISE; GENETICS; GROWTH HORMONE DEFICIENCY; HUMAN; HYPOGONADISM; LABORATORY TEST; PATIENT CARE; PHYSIOTHERAPY; PRADER WILLI SYNDROME; PUBERTY; REVIEW; TREATMENT PLANNING; ADULT; CHILD; INFANT; LONG TERM CARE; PATHOPHYSIOLOGY;

ADULT; CHILD; HUMANS; INFANT; LONG-TERM CARE; PRADER-WILLI SYNDROME;

EID: 4644319938     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (52)

1. Butler MG: Imprinting disorders: Non-Mendelian mechanisms affecting growth. J Pediatr Endocrinol Metab 15:1279-1288, 2002.
2. Prader A, Labhart A, Willi H: Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach Myatonieartigem Zustand im Neugeborenenalter. Schweiz Med Wochenschr 86:1260-1261, 1956.
3. Laurence BM: Hypotonia, hypogonadism and mental retardation in childhood. Arch Dis Child 36:690-710, 1961.
4. Zellweger J: Syndrome of hypotonia-hypomantia-hypogonadism-obesity (HHHO) or Prader-Willi Syndrome. Birth Defects 5:5-17, 1969.
5. Hall BD, Smith DW: Prader-Willi syndrome. A resume of 32 cases including an instance of affected first cousins, one of whom is of normal stature and intelligence. J Pediatr 81:286-293, 1972.
6. Cassidy SB: Prader-Willi syndrome. Curr Probl Pediatr 14:1-55, 1984.
7. Holm VA: The diagnosis of Prader-Willi syndrome, in Holm VA, Sulzbacher SJ, Pipes P (eds): The Prader-Willi Syndrome. Baltimore, University Park Press, 1981, pp 27-44.
8. Bray G, Dahms W, Swerdloff R, et al: The Prader-Willi syndrome: A study of 40 patients and a review of the literature. Medicine (Baltimore) 62:59-80, 1983.
9. Greenswag LR: Adults with Prader-Willi syndrome: A survey of 232 cases. Dev Med Child Neurol 29:145-152, 1987.
10. Greenswag LR, Alexander RC: Early diagnosis in Prader-Willi syndrome: Implications for managing weight and behavior. Dysmorphol Clin Genet 4:8-12, 1990.
11. Ledbetter DH, Riccardi VM, Airhart SD, et al: Deletion of chromosome 15 as a cause of the Prader-Willi syndrome: A review. Am J Med Genet 46:16-25, 1981.
12. Stadler DD: Nutritional management, in Greenswag LR, Alexander R (eds): Management of Prader-Willi Syndrome. New York, Springer-Verlag, 1995, p 88-114.
13. Cassidy SB: Prader-Willi syndrome. J Med Genet 34:917-923, 1997.
14. Glaser B, Hirsch HJ: Prader-Willi syndrome in, Hatchell E (ed): Genetics for Endocrinologists: The Molecular Genetic Basis of Endocrine Disorders. London, Remedica Publishing, 2003, pp 70-74.
15. Nicholls RD, Knepper JL: Genome organization, function and imprinting in Prader-Willi and Angelman syndrome (PWS/AS). Annu Rev Genomics Hum Genet 2:153-157, 2003.
16. Gunay-Aygun M, Schwartz S, Heeger S, et al: The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics 108:e92, 2001.
17. Holm VA, Cassidy SB, Butler MG, et al: Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 91:398-402, 1993.
18. Zipf WB, O'Dorisio TM, Cataland S, et al: Pancreatic polypeptide responses to protein meal challenges in obese but otherwise normal children and obese children with Prader-Willi syndrome. J Clin Endocrinol Metab 57:1074-1080, 1983.
19. Zellweger H: The Prader-Willi syndrome. JAMA 251:1835, 1984.
20. Aughton DJ, Cassidy SB: Physical features of Prader-Willi syndrome in neonates. Am J Dis Child 144:1251-1254, 1990.
21. Butler MG, Meaney F: Standards for selected anthropometric measurements in Prader-Willi syndrome. Pediatrics 88:853-860, 1991.
22. Epstein LH, McCurley J, Valoski A, et al: Growth in obese children treated for obesity. Am J Dis Child 144:1360-1364, 1990.
23. Lee PDK: Endocrine and metabolic aspects of Prader-Willi syndrome, in Greenswag LR, Alexander R (eds): Management of Prader-Willi Syndrome. New York, Springer-Verlag, 1995, pp 32-57.
24. Åkefeldt A, Törnhage CJ, Gillberg C: A woman with Prader-Willi syndrome gives birth to a healthy baby girl. Dev Med Child Neurol 41:789-790, 1999.
25. Schulze A, Mogensen H, Hamborg-Petersen B, et al: Fertility in Prader-Willi syndrome: A case report with Angelman syndrome in the offspring. Acta Paediatr 90:455-459, 2001.
26. Butler MG, Bittel DC, Kibiryeva N, et al: Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics 113:565-573, 2004.
27. Schuster D, Oswei K, Zipf WB: Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism 45:1514-1520, 1996.
28. Angulo M, Castro-Magana M, Mazur B, et al: Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome. J Pediatr Endocrinol Metab 9:393-400, 1996.
29. Angulo M, Castro-Magana M, Uy J: Pituitary evaluation and growth hormone treatment in Prader-Willi syndrome. J Pediatr Endocrinol 4:167-173, 1991.
30. Costeff H, Holm VA, Ruvalcaba R, et al: Growth hormone secretion in Prader-Willi syndrome. Acta Paediatr 79:1059-1062, 1990.
31. Lee PDK, Wilson DM, Roundtree L, et al: Linear growth response to exogenous growth hormone in Prader-Willi syndrome. Am J Med Genet 28:865-871, 1987.
32. Parra A, Cervantes C, Schultz RB: Immunoreactive insulin and growth hormone responses in patients with Prader-Willi syndrome. J Pediatr 83:587-593, 1973.
33. Theodoridis CG, Brown GA, Chance GW, et al: Plasma growth hormone levels in children with the Prader-Willi syndrome. Aust Paediatr J 7:24-27, 1971.
34. Carrel AL, Allen DB: Growth hormone and Prader-Willi syndrome: What we know and have yet to learn. Endocrinologist 13:106-111, 2003.
35. Obata K, Sakazume S, Yoshino A, et al: Effects of 5 years growth hormone treatment in patients with Prader-Willi syndrome. J Pediatr Endocrinol Metab 16:155-162, 2003.
36. Zipf WB: Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy. Acta Paediatr 88:115S-117S, 1999.
37. l'Allemand D, Eiholzer U, Schlumpf M, et al: Carbohydrate metabolism is not impaired after 3 years of growth hormone therapy in children with Prader-Willi syndrome. Horm Res 59:239-248, 2003.
38. Vliet GV, Deal CL, Crock PA, et al: Sudden death in growth hormone-treated children with Prader-Willi syndrome. J Pediatr 144:120-131, 2004.
39. Haqq AM, Stadler DD, Rosenfeld RG, et al: Circulating ghrelin levels are suppressed by meals and octreotide therapy in children with Prader-Willi syndrome. J Clin Endocrinol Metab 88:3573-3576, 2003.
40. DelParigi A, Tschop M, Heiman ML, et al: High circulating ghrelin: A potential cause for hyperphagia and obesity in Prader-Willi syndrome. J Clin Endocrinol Metab 87:5461-5464, 2002.
41. Haqq AM, Farooqi IS, O'Rahilly S, et al: Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 88:174-178, 2003.
42. Cummings DE, Clement K, Purnell JQ, et al: Elevated plasma ghrelin levels in Prader-Willi syndrome. Nat Med 7:643-644, 2002.
43. Cummings DE, Purnell JQ, Frayo RS, et al: A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50:1714-1719, 2001.
44. Wren AM, Seal LJ, Cohen MA, et al: Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992, 2001.
45. Eiholzer U, Nordmann Y, l'Allemand D, et al: Improving body composition and physical activity in Prader-Willi syndrome. J Pediatr 142:73-78, 2003.
46. Wigren M, Hansen S: Prader-Willi syndrome: Clinical picture, psychosocial support and current management. Child Care Health Dev 29:446-456, 2003.
47. Hodapp RM, Dykens EM, Masino LL: Families of children with Prader-Willi syndrome: Stress-support and relations to child characteristics. J Autism Dev Disord 27:11-24, 1997.
48. Van Lieshout CF, De Meyer RE, Curfs LMG, et al: Family context, parental behavior and personality profiles of children and adolescents with Prader-Willi, Fragile-X or Williams syndrome. J Child Psychol Psychiatry 39:699-710, 1998.
49. Whitman B, Greenswag L, Boyt M: The use and impact of psychotropic medications for managing behavior in persons with Prader-Willi syndrome. Presented at the 13th Annual Prader-Willi Scientific Conference, Columbus, Ohio, 1998.
50. Carrel AL, Myers SE, Whitman BY, et al: Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study. J Pediatr 134:215-221, 1999.
51. Ritzen EM, Lindgren AC, Hagenas L, et al: Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group. Pediatr Endocrinol Metab 12(Suppl 1):345-349, 1999.
52. Hoybye C: Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment. Growth Horm IGF Res 14:1-15, 2004.